Showing results (401-410 of 2,117) with videos related to
Sort By:
Pageof 212
International Clinical Psychopharmacology|July 1, 1986
Violent and self-injurious behaviour in mentally handicapped patients--psychopharmacological controlS G Read, D H BatchelorInternational Clinical Psychopharmacology|April 1, 1987
Lack of sleep-inducing properties of propranolol (80 mg) in chronic insomniacs previously treated by common hypnotic medicationsP Danjou, A Puech, D Warot, et al.International Clinical Psychopharmacology|April 1, 1988
Attention deficit disorder and methylphenidate: a multi-step analysis of dose-response effects on children's cardiovascular functioningK L Kelly, M D Rapport, G J DuPaulInternational Clinical Psychopharmacology|January 1, 1987
Treatment-resistant schizophrenia: controlled study of moderate- and high-dose thiothixeneC C Huang, R P Gerhardstein, D Y Kim, et al.International Clinical Psychopharmacology|September 27, 2022
Patterns of antipsychotic prescription and accelerometer-based physical activity levels in people with schizophrenia spectrum disorders: a multicenter, prospective studyVincenzo Oliva, Giuseppe Fanelli, Manuel Zamparini, et al.International Clinical Psychopharmacology|September 27, 2022
Longitudinal changes in clozapine dose in patients with treatment-resistant schizophrenia: a 5-year retrospective cohort studyMasaru Tsukahara, Ryuhei So, Shinichiro Nakajima, et al.International Clinical Psychopharmacology|November 26, 2021
Olanzapine intramuscular shows better efficacy than zuclopenthixol acetate intramuscular in reducing the need for restraint, but not in comparison to haloperidol intramuscularOmri Sinai, Rafael Stryjer, Esther Bloemhof-Bris, et al.International Clinical Psychopharmacology|November 26, 2021
Tetrahydrocannabinol fails to reduce hair pulling or skin picking: results of a double-blind, placebo-controlled study of dronabinolJon E Grant, Stephanie Valle, Eve Chesivoir, et al.International Clinical Psychopharmacology|May 17, 2019
Cytochrome P450-mediated inhibition of venlafaxine metabolism by trimipramineChristoph Kowalewski, Ekkehard Haen, Christoph Hiemke, et al.International Clinical Psychopharmacology|July 1, 1986
Fluvoxamine in the treatment of the older depressed patient; double-blind, placebo-controlled dataJ S WakelinPageof 212